A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531

Completed

Plain-English translation of NCT02956850 on ClinicalTrials.gov ↗ · Source last updated February 2024 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(18 sites)

Bulgaria

Gastroenterology department, Second clinic of internal diseases, Sofia

COMAC Medical; Clinical Research Unit for Phase I, Sofia

Hong Kong

Queen Mary Hospital, Hong Kong

The Chinese University of Hong Kong, Shatin

Italy

Azienda Ospedaliero Universitaria Di Modena Policlinico; U.O. Farmacia, Modena, Emilia-Romagna